Net Asset Value(s)

Palmer Square EUR CLO Senior Debt Index UCITS ETF reported a 10 September 2026 NAV of €51.8003 for the EUR share class and £44.5266 for the GBP share class. The fund had 1.025 million units outstanding and shareholder equity of €53.10 million; the table provides routine fund valuation data without performance commentary or a material market catalyst.

Analysis

This is an administrative NAV observation rather than a credit fundamental catalyst; it provides no evidence on CLO collateral performance, liability costs, defaults, reinvestment activity, or secondary-market liquidity. A single end-of-day NAV should not be interpreted as a tradable signal, particularly for senior CLO exposure where observable ETF pricing can diverge from underlying loan marks during risk-off sessions.

The actionable issue is structure and execution: the EUR and GBP lines reference the same underlying vehicle, so any apparent return differential should primarily reflect currency translation and trading spreads rather than distinct credit exposure. For the next 1-3 months, the relevant drivers are leveraged-loan default expectations, downgrade volume, loan-price dispersion, and the path of short-term rates; a sustained rise in CLO AAA spread levels or deterioration in loan-market technicals would matter far more than this publication. No directional trade is warranted from the disclosed data alone.

Key Decisions for Investors

• No new position based solely on this NAV release; classify PCL0/PCLS as watch-list instruments rather than a credit signal.
• If seeking senior-CLO exposure, compare executable bid/ask prices in PCL0 and PCLS against NAV after adjusting for EUR/GBP FX; only consider entry when the discount exceeds estimated transaction costs plus a meaningful liquidity buffer.
• Set alerts for a 15-25bp widening in AAA CLO spreads, a material increase in leveraged-loan downgrades, or a sharp decline in broadly syndicated loan prices; those conditions would create a more informative entry-point assessment over the next 1-3 months.